Are patients taking statins, which are HMG-CoA reductase inhibitors, to reduces their cholesterol, the danger of being deficient in coenzyme Q?
Wood
E J
EJ
School of Biochemistry & Microbiology, University of Leeds, Leeds LS2 9JY, UK. e.j.wood@Leeds.ac.uk
D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008928:Mitochondria / Q000378:metabolism; D018482:Muscle, Skeletal / Q000378:metabolism; D013729:Terpenes / Q000378:metabolism; D014451:Ubiquinone / Q000097:blood / Q000172:deficiency*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D013729:Terpenes; D014451:Ubiquinone